EZH2 Regulates the Proliferation-Senescence Balance and Tumor–Stromal Signaling in Lung Adenocarcinoma
International Journal of Molecular Sciences · 30.06.2026 · 27 (13) · 5914
DOI: 10.3390/ijms27135914 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 30.06.2026. Verfasst von Kamil Saramowicz und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Chemistry and Biochemistry, Medical University of Lodz, 92-215 Lodz, Poland. Hauptthemen laut MEDLINE: Enhancer of Zeste Homolog 2 Protein, Cellular Senescence, Adenocarcinoma of Lung, Lung Neoplasms. Die Arbeit nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Lodz, Ministry of Science and Higher Education.
Abstract (Originalsprache)
Enhancer of zeste homolog 2 (EZH2), the catalytic component of the polycomb repressive complex 2, is frequently overexpressed in lung adenocarcinoma and contributes to transcriptional programs that support tumor proliferation and cellular plasticity. However, its role in regulating senescence-associated signaling and tumor–stromal interactions in lung cancer remains incompletely understood. In this study, we combined transcriptomic analysis of The Cancer Genome Atlas lung adenocarcinoma cohort with functional characterization of EZH2 targeting in A549 cells using the catalytic inhibitor EPZ6438 and the EZH2 degrader MS1943. Elevated EZH2 expression was associated with enrichment of cell cycle-related transcriptional pathways. Pharmacological targeting of EZH2 reduced proliferation, migration, stemness-associated features, and sphere-forming capacity, with more pronounced effects observed following EZH2 degradation. Both compounds promoted features consistent with senescence-associated phenotypic remodeling characterized by increased expression of p16 and p21, enhanced β-galactosidase activity, G0/G1 cell cycle arrest, and increased expression of cytokines commonly associated with senescence-related secretory signaling, including IL-6, CCL2, and CXCL8. Conditioned medium from treated tumor cells promoted activation of primary lung fibroblasts, indicating functional paracrine microenvironmental remodeling. Importantly, EZH2 targeting elicited cytostatic responses without induction of apoptosis. Collectively, these findings suggest that EZH2 contributes to regulation of proliferation-associated and senescence-associated phenotypic programs together with stromal signaling in lung adenocarcinoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Chemistry and Biochemistry, Medical University of Lodz, 92-215 Lodz, Poland.
- Department of Bioinorganic Chemistry, Medical University of Lodz, 90-151 Lodz, Poland.
- College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan 430074, China.
- Key Laboratory of Molecular Biophysics of the Ministry of Education, Wuhan 430074, China.
ORCID-Profile: Kamil Saramowicz, Angelika A Adamus-Grabicka, Joanna Sikora, Wioletta Rozpędek-Kamińska
Förderung
- Medical University of Lodz
- Ministry of Science and Higher Education
Zitieren
APA
Saramowicz, K., Piesiewicz, M., Adamus-Grabicka, A. A., Zhao, P., Sikora, J., & Rozpędek-Kamińska, W. (2026). EZH2 Regulates the Proliferation-Senescence Balance and Tumor–Stromal Signaling in Lung Adenocarcinoma. International Journal of Molecular Sciences, 27(13), 5914. https://doi.org/10.3390/ijms27135914
Vancouver
Saramowicz K, Piesiewicz M, Adamus-Grabicka AA, Zhao P, Sikora J, Rozpędek-Kamińska W. EZH2 Regulates the Proliferation-Senescence Balance and Tumor–Stromal Signaling in Lung Adenocarcinoma. International Journal of Molecular Sciences. 2026;27(13):5914. doi:10.3390/ijms27135914
BibTeX
@article{Saramowicz2026,
author = {Saramowicz, Kamil and Piesiewicz, Matylda and Adamus-Grabicka, Angelika A and Zhao, Pengyu and Sikora, Joanna and Rozpędek-Kamińska, Wioletta},
title = {EZH2 Regulates the Proliferation-Senescence Balance and Tumor–Stromal Signaling in Lung Adenocarcinoma},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {13},
pages = {5914},
doi = {10.3390/ijms27135914}
}
EUVIMED